If anyone is looking for a possible Bio that is on the OTCBB that could potentially be ready to move to Nasdaq soon: IPIX.
They have never failed a trial.
3 extremely valuable drugs
Today the CEO shared that they have almost 20 CDAs signed.
The first partnership will unlock this companies value.
It has been really beaten down by short writers on seeking-alpha and other nefarious sites over the past 3 years and even defended themselves through a lawsuit by an ambulance chasing firm who were followers of the pos seeking alpha author.
Do your own DD. But a short term catalyst is phase 2b Oral psoriasis top line data - first quarter 2018. We are looking to beat Otezla at 33% PASI 75
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.